TFX
Teleflex Incorporated NYSE Listed Mar 17, 1980$131.76
Mkt Cap $5.8B
52w Low $100.18
80.0% of range
52w High $139.67
50d MA $119.29
200d MA $118.75
P/E (TTM)
-6.0x
EV/EBITDA
25.7x
P/B
1.7x
Debt/Equity
0.9x
ROE
-22.9%
P/FCF
22.2x
RSI (14)
—
ATR (14)
—
Beta
0.83
50d MA
$119.29
200d MA
$118.75
Avg Volume
948.5K
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
550 East Swedesford Road · Wayne, PA 19087-1603 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 123.23 | +5.2% | +6.9% | — | — | — | — | — |
| Feb 26, 2026 | BMO | 3.73 | 1.93 | -48.3% | 111.89 | -3.0% | +6.4% | +9.1% | +9.9% | +9.2% | +6.5% | — |
| Nov 6, 2025 | BMO | 3.38 | 3.67 | +8.6% | 124.75 | -3.7% | -13.0% | -12.3% | -13.5% | -10.0% | -10.6% | — |
| Jul 31, 2025 | BMO | 3.36 | 3.73 | +11.0% | 113.91 | +8.1% | +4.9% | +1.7% | +1.9% | +0.8% | -1.6% | — |
| May 1, 2025 | BMO | 2.88 | 2.91 | +1.0% | 137.05 | -3.0% | -8.2% | -7.8% | -10.3% | -12.0% | -10.9% | — |
| Feb 27, 2025 | BMO | 3.86 | 3.89 | +0.8% | 177.63 | -11.9% | -21.7% | -25.3% | -23.9% | -26.4% | -24.5% | — |
| Oct 31, 2024 | BMO | 3.38 | 3.49 | +3.3% | 235.22 | -11.8% | -14.5% | -10.2% | -11.9% | -13.5% | -14.2% | — |
| Aug 1, 2024 | BMO | 3.33 | 3.42 | +2.7% | 220.92 | +2.6% | +6.8% | +7.3% | +5.6% | +4.5% | +2.0% | — |
| May 2, 2024 | BMO | 3.07 | 3.21 | +4.6% | 211.54 | -1.5% | -6.1% | -4.0% | -5.0% | -4.7% | -5.2% | — |
| Feb 22, 2024 | BMO | 3.26 | 3.38 | +3.7% | 250.95 | -3.2% | -5.3% | -5.3% | -9.2% | -9.9% | -10.4% | — |
| Nov 2, 2023 | BMO | 3.27 | 3.64 | +11.3% | 187.51 | +2.4% | +11.6% | +12.5% | +13.6% | +9.2% | +6.9% | — |
| Aug 3, 2023 | BMO | 3.21 | 3.41 | +6.2% | 248.61 | -1.5% | -3.7% | -4.3% | -3.4% | -7.6% | -7.9% | — |
| May 4, 2023 | BMO | 2.97 | 3.09 | +4.0% | 272.12 | -4.1% | -8.5% | -5.2% | -4.8% | -7.4% | -8.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8 | RBC Capital Mkts | Upgrade | Sector Perform → Outperform | $155 | — | — | — | — | — | — | — | — |
| Mar 27 | Raymond James | Upgrade | Market Perform → Outperform | — | $110.49 | $114.54 | +3.7% | +5.2% | +4.0% | +8.3% | +7.2% | +6.6% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $119.02 | $117.72 | -1.1% | +2.6% | +3.3% | +2.7% | +0.1% | -1.2% |
| Feb 27 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $119.02 | $117.72 | -1.1% | +2.6% | +3.3% | +2.7% | +0.1% | -1.2% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $111.89 | $108.54 | -3.0% | +6.4% | +9.1% | +9.9% | +9.2% | +6.5% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $105.33 | $104.71 | -0.6% | +0.1% | -0.9% | -1.9% | -2.8% | +0.6% |
| Jan 27 | Needham | Upgrade | Hold → Buy | — | $104.20 | $104.89 | +0.7% | +0.3% | +1.1% | +1.2% | +0.2% | -0.8% |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $125.10 | $125.00 | -0.1% | -0.5% | -2.6% | -0.5% | -2.2% | -2.2% |
| Dec 10 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $131.25 | $130.75 | -0.4% | -0.6% | -3.0% | -3.3% | -3.5% | -4.9% |
| Nov 10 | Truist | Maintains | Hold → Hold | — | $109.40 | $110.00 | +0.5% | -1.3% | +2.6% | +1.9% | +0.0% | -2.2% |
| Nov 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $108.51 | $108.29 | -0.2% | +0.8% | -0.5% | +3.5% | +2.7% | +0.9% |
| Nov 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $108.51 | $108.29 | -0.2% | +0.8% | -0.5% | +3.5% | +2.7% | +0.9% |
| Aug 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $119.50 | $119.35 | -0.1% | -3.0% | -2.9% | -3.9% | -6.2% | -3.4% |
| Aug 1 | Mizuho | Maintains | Neutral → Neutral | — | $119.50 | $119.35 | -0.1% | -3.0% | -2.9% | -3.9% | -6.2% | -3.4% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $119.50 | $119.35 | -0.1% | -3.0% | -2.9% | -3.9% | -6.2% | -3.4% |
| Jul 16 | Mizuho | Maintains | Neutral → Neutral | — | $113.47 | $114.01 | +0.5% | -0.1% | +0.1% | -2.1% | -3.2% | +1.5% |
| Jul 15 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $115.75 | $116.01 | +0.2% | -2.0% | -2.1% | -1.9% | -4.1% | -5.1% |
| May 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $126.41 | $126.40 | -0.0% | -2.8% | -4.6% | -3.4% | -0.2% | -1.0% |
| May 5 | Truist | Maintains | Hold → Hold | — | $126.41 | $126.40 | -0.0% | -2.8% | -4.6% | -3.4% | -0.2% | -1.0% |
| May 2 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $125.87 | $128.55 | +2.1% | +0.4% | -2.4% | -4.2% | -3.0% | +0.2% |
| May 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $125.87 | $128.55 | +2.1% | +0.4% | -2.4% | -4.2% | -3.0% | +0.2% |
| Apr 11 | Truist | Maintains | Hold → Hold | — | $129.07 | $129.10 | +0.0% | +0.6% | +2.3% | -0.4% | -0.7% | +0.3% |
| Apr 2 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $140.30 | $139.47 | -0.6% | +0.8% | -1.6% | -6.0% | -6.8% | -9.4% |
| Mar 12 | Needham | Maintains | Hold → Hold | — | $138.82 | $138.55 | -0.2% | -2.4% | -1.8% | -0.8% | +0.7% | +0.8% |
| Mar 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $130.79 | $130.96 | +0.1% | +2.6% | +4.2% | +6.9% | +5.9% | +6.1% |
| Mar 4 | BofA Securities | Downgrade | Neutral → Underperform | — | $135.13 | $134.57 | -0.4% | -3.2% | -0.7% | +0.8% | +3.5% | +2.5% |
| Mar 3 | Truist | Maintains | Hold → Hold | — | $132.75 | $134.21 | +1.1% | +1.8% | -1.5% | +1.1% | +2.6% | +5.3% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $139.11 | $135.45 | -2.6% | -4.6% | -2.9% | -6.0% | -3.6% | -2.0% |
| Feb 28 | Piper Sandler | Downgrade | Overweight → Neutral | — | $139.11 | $135.45 | -2.6% | -4.6% | -2.9% | -6.0% | -3.6% | -2.0% |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $178.28 | $177.40 | -0.5% | -3.2% | -2.0% | -0.1% | -0.0% | -0.6% |
| Dec 16 | Needham | Maintains | Hold → Hold | — | $180.14 | $179.40 | -0.4% | -1.6% | -1.0% | -4.2% | -3.0% | -1.1% |
| Nov 4 | Truist | Maintains | Hold → Hold | — | $211.21 | $210.31 | -0.4% | -1.8% | -3.7% | -4.4% | -6.2% | -7.4% |
| Nov 1 | RBC Capital | Maintains | Outperform → Outperform | — | $201.06 | $201.94 | +0.4% | +5.0% | +3.1% | +1.2% | +0.4% | -1.5% |
| Nov 1 | Mizuho | Maintains | Neutral → Neutral | — | $201.06 | $201.94 | +0.4% | +5.0% | +3.1% | +1.2% | +0.4% | -1.5% |
| Oct 14 | Truist | Maintains | Hold → Hold | — | $236.03 | $236.20 | +0.1% | +0.6% | -0.3% | -0.4% | -0.8% | +1.7% |
| Oct 8 | RBC Capital | Maintains | Outperform → Outperform | — | $232.96 | $234.28 | +0.6% | +0.9% | +0.6% | +0.7% | +1.3% | +1.9% |
| Aug 6 | RBC Capital | Maintains | Outperform → Outperform | — | $233.33 | $234.14 | +0.3% | -1.1% | -3.4% | -1.4% | -1.6% | -2.2% |
| Aug 5 | Truist | Maintains | Hold → Hold | — | $237.13 | $232.89 | -1.8% | -1.6% | -2.7% | -5.0% | -3.0% | -3.2% |
| Aug 2 | RBC Capital | Maintains | Outperform → Outperform | — | $235.95 | $237.37 | +0.6% | +0.5% | -1.1% | -2.2% | -4.5% | -2.5% |
| Aug 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $235.95 | $237.37 | +0.6% | +0.5% | -1.1% | -2.2% | -4.5% | -2.5% |
| Jul 16 | Truist | Maintains | Hold → Hold | — | $219.84 | $220.69 | +0.4% | +4.3% | +4.8% | +0.2% | +0.9% | +1.3% |
| Jul 9 | Truist | Maintains | Hold → Hold | — | $211.73 | $212.55 | +0.4% | +3.0% | +4.2% | +6.0% | +4.1% | +3.8% |
| Jul 1 | Piper Sandler | Upgrade | Neutral → Overweight | — | $210.33 | $214.27 | +1.9% | +0.5% | +0.4% | +0.5% | +1.8% | +0.7% |
| May 3 | Truist | Maintains | Hold → Hold | — | $198.73 | $201.19 | +1.2% | +2.2% | +1.1% | +1.4% | +0.9% | +3.0% |
| Feb 23 | Truist | Maintains | Hold → Hold | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.1% | -4.9% | -5.4% | -6.3% |
| Feb 23 | RBC Capital | Maintains | Outperform → Outperform | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.1% | -4.9% | -5.4% | -6.3% |
| Feb 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.1% | -4.9% | -5.4% | -6.3% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $248.34 | $251.95 | +1.5% | +0.3% | -1.0% | -1.4% | -0.8% | -0.6% |
| Dec 22 | Truist | Maintains | Hold → Hold | — | $251.43 | $252.52 | +0.4% | -0.2% | +0.3% | -0.4% | -0.7% | -0.8% |
| Dec 20 | Raymond James | Maintains | Outperform → Outperform | — | $253.83 | $253.60 | -0.1% | -2.5% | -0.9% | -1.1% | -0.7% | -1.3% |
No insider trades available.
8-K · 2.02
!! High
Teleflex Incorporated -- 8-K 2.02: Earnings Results
Teleflex reported Q1 2026 financial results on May 7, 2026, disclosing its operational performance and financial condition for the quarter ended March 31, 2026.
May 7
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Teleflex's planned asset sales generating $1.8 billion for shareholder buybacks and debt reduction demonstrate management's commitment to value creation, supporting stock appreciation while strengthening the balance sheet.
Mar 27
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Teleflex's planned Acute Care and Urology division sale faces regulatory scrutiny with an HSR Second Request, potentially delaying the transaction and creating uncertainty around deal completion timing and valuation.
Mar 17
8-K · 7.01
! Medium
Teleflex Incorporated -- 8-K 7.01: Regulation FD Disclosure
Teleflex's voluntary disclosure suggests management is proactively communicating material information to investors, potentially signaling confidence in operations or addressing market concerns that could impact stock valuation.
Feb 26
Data updated apr 27, 2026 4:34am
· Source: massive.com